EUVIMEDEUVIMED entdecken
Open Access

Targeted nanoparticles for placenta-specific drug delivery in pregnant rhesus macaques

Jenna K Schmidt, Ann M Mitzey, Logan T Keding, Sarah A Shaw, Lewis Renshall, Frances Beards, Mona H Al-Mugotir, Heather A Simmons, Puja Basu, Michele L Schotzko, Emily Ren, Thaddeus G Golos und 1 weitere

Theranostics · 2026

DOI: 10.7150/thno.115081 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, 2026. Verfasst von Jenna K Schmidt und 12 weiteren Autor:innen. Beteiligte Einrichtung: Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI, USA. Hauptthemen laut MEDLINE: Placenta, Liposomes, Nanoparticles, Drug Delivery Systems. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NCATS NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rationale

To reduce the risks associated with systemic drug administration in pregnancy and create new therapies for placental dysfunction, we have previously developed targeted liposomes capable of selective delivery of payloads to the placentas of pregnant mice. In this study, we assessed whether these liposomes selectively accumulated in the placentas of nonhuman primates and evaluated the maternal systemic response to liposome infusion.

Methods

Liposomes were produced using the thin-film method, decorated with the placental homing peptide CRGDKGPDC (iRGD) or non-targeting peptide ARALPSQRSR (ARA) and loaded with 5(6)carboxyfluorescein. Liposomes were infused intravenously into pregnant rhesus macaques early in gestation, at days 45-64 (iRGD, n = 4; ARA, n = 1) or mid-gestation, at days 84-100 (iRGD, n = 4; ARA, n = 2; term = 165 days). After 24 h, maternal blood and maternal, uteroplacental and fetal tissues were collected for evaluation.

Results

Liposome infusions were well tolerated, with no adverse clinical reactions or abnormal placental or fetal pathology. Maternal plasma hormone, cytokine and chemokine levels, and complete blood cell counts remained broadly stable for the duration of the treatment period. iRGD-decorated liposomes accumulated in both placental discs of each animal, varying in intensity and tissue distribution. Limited fluorescence was noted in some sections of maternal liver, spleen, kidney and mesenteric lymph nodes, but no visible signal was observed in other maternal or fetal tissues examined. In contrast, ARA-decorated liposomes exhibited a widespread tissue distribution, with fluorescence observed in the majority of maternal, uteroplacental and fetal tissues examined.

Conclusions

This study confirms that iRGD-decorated liposomes selectively accumulate in the rhesus macaque placenta in vivo, but are not transferred to the fetus. Their composition is compatible with short term courses of treatment, indicating that this nanoparticle formulation may be suitable for targeted placental delivery of therapeutic payloads in human pregnancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PlacentaLiposomesNanoparticlesDrug Delivery SystemsAnimalsFemalePregnancyMacaca mulattaFluoresceins

Stichwörter der Autor:innen

drug deliveryliposomeplacentapregnancytargeting.

Substanzen

LiposomesFluoresceins6-carboxyfluorescein

Autor:innen und Institutionen

  • Wisconsin National Primate Research Center, University of Wisconsin-Madison, Madison, WI, USA.
  • Department of Obstetrics and Gynecology, University of Wisconsin-Madison, University of Wisconsin-Madison, WI, USA.
  • Maternal and Fetal Health Research Centre, Division of Developmental Biology and Medicine, The University of Manchester, Manchester, UK.
  • St. Mary's Hospital, Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK.
  • Olson Center for Women's Health, Department of Obstetrics and Gynecology, University of Nebraska Medical Center, Omaha, NE, USA.
  • Department of Comparative Biosciences, School of Veterinary Medicine, University of Wisconsin-Madison, WI, USA.

Förderung

  • NCI NIH HHS
  • NCATS NIH HHS
  • NIH HHS
  • NCRR NIH HHS
  • NICHD NIH HHS

Zitieren

APA

Schmidt, J. K., Mitzey, A. M., Keding, L. T., Shaw, S. A., Renshall, L., Beards, F., Al-Mugotir, M. H., Simmons, H. A., Basu, P., Schotzko, M. L., Ren, E., Golos, T. G., & Harris, L. K. (2026). Targeted nanoparticles for placenta-specific drug delivery in pregnant rhesus macaques. Theranostics. https://doi.org/10.7150/thno.115081

Vancouver

Schmidt JK, Mitzey AM, Keding LT, Shaw SA, Renshall L, Beards F, et al. Targeted nanoparticles for placenta-specific drug delivery in pregnant rhesus macaques. Theranostics. 2026. doi:10.7150/thno.115081

BibTeX
@article{Schmidt2026,
  author = {Schmidt, Jenna K and Mitzey, Ann M and Keding, Logan T and Shaw, Sarah A and Renshall, Lewis and Beards, Frances and Al-Mugotir, Mona H and Simmons, Heather A and Basu, Puja and Schotzko, Michele L and Ren, Emily and Golos, Thaddeus G and Harris, Lynda K},
  title = {Targeted nanoparticles for placenta-specific drug delivery in pregnant rhesus macaques},
  journal = {Theranostics},
  year = {2026},
  doi = {10.7150/thno.115081}
}
Kostenlos starten →